ARWR
Arrowhead Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$86.34
−0.17%Margins
Gross margin
100.0%
EBITDA margin
-21.0%
EBIT margin
-33.8%
Net margin
-47.8%
FCF margin
-11.2%
-68.7%
Return on equity
-15.1%
Return on assets
-17.0%
Return on invested capital
0.31x
Asset turnover
-$59.1M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026